MEXICO CITY (Reuters) – Mexico said Wednesday in Moscow that it sought phase 3 testing of Russia’s coronavirus vaccine, as part of the Latin American country’s intensified efforts to ensure the immediate source of an effective pandemic drug.
After a meeting with the Russian ambassador to Mexico, Viktor Koronelli, Foreign Minister Marcelo Ebrard said on Twitter that he had expressed interest in conducting large-scale human trials “to get the vaccine as soon as you can imagine in Mexico.”
Russia has already produced the first batch of its new vaccine, giving its approval before trials that would generally involve thousands of participants.These phase 3 trials are considered essential precursors of a vaccine to discharge regulatory approval.
The race to produce a vaccine has a festival of influence and prestige among the main powers, while emerging economies seek to ensure an equitable distribution of medicines.
The Russian vaccine, called “Sputnik V” in homage to the world’s first satellite introduced through the Soviet Union during the Cold War, is the first to enter production and will be deployed until the end of the month.
Russian President Vladimir Putin trusted the safe public.
His Mexican counterpart Andrés Manuel López Obrador said this week that he would volunteer to be among the first to check the Russian vaccine if it was effective.
Mexico has already agreed to manufacture a candidate vaccine that is being developed through AstraZeneca of the United Kingdom and the University of Oxford to supply the Latin American market.
It’s also for last-minute testing for the US company Johnson
(Information through Miguel Gutierrez; Additional information through Frank Jack Daniel; Edited through Dave Graham, Lisa Shumaker and Richard Pullin)
Subscribe
Sign up for our news explosion.